APGE - CIK 0001974640
Apogee Therapeutics, Inc. has filed 262 documents with the SEC between 2023 and 2026. The most frequent type is insider trade (88 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-27 | 2026-05-26 |
| Major company event | 8-K | 2026-05-27 | 2026-05-27 |
| Insider trade | 4 | 2026-05-15 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-13 | - |
| Quarterly report | 10-Q | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-11 | 2026-05-11 |
| Insider trade | 4 | 2026-05-08 | 2026-05-06 |
| Insider sale notice | 144 | 2026-05-06 | - |
| Insider trade | 4 | 2026-05-04 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-01 | - |
| Proxy materials | DEFA14A | 2026-04-24 | - |
| Annual report to shareholders | ARS | 2026-04-24 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-04-24 | 2026-06-09 |
| Major company event | 8-K | 2026-04-24 | 2026-04-21 |
| Insider trade | 4 | 2026-04-20 | 2026-04-16 |
| Insider trade | 4 | 2026-04-17 | 2026-04-16 |
| Insider trade | 4 | 2026-04-10 | 2026-04-08 |
| SCHEDULE 13G/A | - | 2026-04-08 | - |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-04-03 | 2026-04-01 |
| Insider trade | 4 | 2026-03-27 | 2026-03-25 |
| SCHEDULE 13D/A | - | 2026-03-27 | - |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Insider sale notice | 144 | 2026-03-25 | - |
| Major company event | 8-K | 2026-03-25 | 2026-03-24 |
| Prospectus supplement | 424B5 | 2026-03-25 | - |
| Prospectus supplement | 424B5 | 2026-03-23 | - |
| Major company event | 8-K | 2026-03-23 | 2026-03-23 |
| Insider trade | 4 | 2026-03-13 | 2026-03-11 |
| SCHEDULE 13G | - | 2026-03-06 | - |
| Insider trade | 4 | 2026-03-06 | 2026-03-04 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Annual report | 10-K | 2026-03-02 | 2025-12-31 |
| Major company event | 8-K | 2026-03-02 | 2026-03-02 |
| Employee stock plan | S-8 | 2026-03-02 | - |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| Insider trade | 4 | 2026-02-13 | 2026-02-11 |
| Insider sale notice | 144 | 2026-02-11 | - |
| SCHEDULE 13G/A | - | 2026-02-10 | - |
| Insider trade | 4 | 2026-02-04 | 2026-02-04 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| SCHEDULE 13G | - | 2026-01-30 | - |
| Insider trade | 4 | 2026-01-22 | 2026-01-22 |
| Insider sale notice | 144 | 2026-01-22 | - |
| SCHEDULE 13D/A | - | 2026-01-22 | - |
| Insider trade | 4 | 2026-01-16 | 2026-01-14 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider sale notice | 144 | 2026-01-07 | - |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |